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Editors: Anton N. Sidawy and Bruce A. PerlerVariations in the utilization of endovascular aneurysm repair reflect
population risk factors and disease prevalence
Tina T. Ng, James Mirocha, David Magner, Bruce L. Gewertz
Objective: Highly variable utilization rates for a diverse group of surgical
procedures are commonly ascribed to physician practice patterns rather
than clinical considerations. A previous investigation by our group showed
that variations in the rates of carotid endarterectomy (CEA) actually
reflected regional risk factors for atherosclerosis, not physician density or
other socio-economic drivers. In this study, we examine the use of endovas-
cular abdominal aortic aneurysm repair (EVAR) over six years to test our
hypothesis that the utilization of innovative vascular procedures by vascular
surgeons more closely reflects disease prevalence and consistent clinical
judgment than non-medical factors.
Methods: The Nationwide Inpatient Samples and State Inpatient Databases
(2001-2006) were accessed to document the number and type of aneurysm
repairs (EVAR versus open). Multiple metrics pertaining to clinical risk
factors, socioeconomic status, access to care, provider distribution, and
local healthcare capacity were quantitated for each state. We performed
bivariate analysis, Pearson (PC) or Spearman (SC) correlations, and multiple
regression modeling.
Results: The total number of aneurysms repaired has not changed signifi-
cantly (from 45,828 in 2001 to 45,111 in 2006). Over the same interval,
the number of open AAA repair nationwide decreased by 48% while the
number of AAA repaired endovascularly increased by 105%. In 2005, the utili-
zation rate of EVAR among 29 states ranged widely from 39.3% to 69.9%. Use
of EVAR was highest in states with higher incidences of aneurysms (PC = 0.43,
P < .05), greater number of deaths from heart disease (PC = 0.42, P < .05),
greater number of diabetes discharges (PC = 0.48, P < .005), higher number
of carotid stenosis discharges (PC = 0.40, P < .05), and higher number of
chronic obstructive pulmonary disorder (COPD) discharges (SC = 0.43,
P < .05). Regional malpractice pressure, specifically the number of paid
claims and mean malpractice premium, both exhibited positive correlations
with the EVAR rate. The number of physicians, vascular surgeons, hospital
beds, teaching hospitals, or trauma centers did not predict high utilization
of EVAR nor did the other socio-economic indices tested.
Conclusion: While there was substantial regional variation in the use of
EVAR, utilization of the less morbid procedure was well correlated with high-
er risk populations (number of diabetic patients and deaths secondary to
heart disease). Contrary to other studies of regional discrepancies in the
utilization of some surgical procedures, it appears that the utilization of
EVAR was not associated with physician distribution, socioeconomics, or
other non-medical factors.The role of robotic endovascular catheters in fenestrated stent grafting
Celia V. Riga, Nicholas Cheshire, Mohamad Hamady, Colin D. Bicknell* Full articles available online at www.jvascsurg.org
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doi:10.1016/S1078-5884(10)00186-3Objective: Fenestrated stent grafting has allowed the treatment of complex
thoraco-abdominal aneurysm disease via a totally endovascular approach,
but the procedure can be technically challenging and time consuming. We
investigated whether this procedure may be enhanced by remotely steer-
able robotic endovascular catheters.
Methods: A four-vessel fenestrated stent graft partially deployed within
a computed tomography (CT)-reconstructed pulsatile thoraco-abdominal
aneurysm silicon model was used. Fifteen operators of varying endovascular
experience were recruited to participate in the study and divided three
groups, based upon their endovascular experience: group A (n = 4,
100e200 endovascular procedures, group B (n = 5, 200e300), and group C
(n = 6, >300). All operators were asked to cannulate the renal and visceral
vessels under fluoroscopic guidance, using conventional and robotic
techniques. Quantitative (catheterization times and wire/catheter tip
movements) and qualitative metrics (procedure-specific-rating scale
[IC3ST]), which grades operators on catheter use, instrumentation, success-
ful cannulation/catheterization, and overall performance were compared.
Results: Median procedure time for cannulation of all four vessels were
reduced using the robotic system were (2.87 min, interquartile range
[IQR; 2.20-3.90] versus 17.24 min [11.90-19.80]; P < .001) for each individual
operator, regardless of the level of endovascular experience. The total
number of wire/catheter movements taken to complete the task was also
significantly reduced (38, IQR [29-57] versus 454 [283-687]; P < .001). There
were significant differences in time and movement for cannulation of each
individual vessel in the phantom. Robotic catheter operator radiation expo-
sure was negligible as the robotic workstation is remote and away from the
radiation source. Overall performance scores significantly improved using
the robotic system, despite minimal operator exposure to this technology
(IC3ST score 29/35, IQR [22.8-30.7] versus 19/35 [13-24.3]; P = .002). Each
group of operators demonstrated an improvement in performance with
robotic cannulation. For group A, median IC3ST score was 28/35, IQR
(22-33) versus 15/35 (11-20); P = .04; for group B, 30/35 (27-31) versus
19/35 (18-24); P = .07; and for group C, 28.8/35 (28.5-29) versus 22/35
(16-24); P = .06. For groups B and C, these differences did not reach statis-
tical significance.
Conclusion: Robotic catheterization of target vessels during this procedure
is feasible and minimizes radiation exposure for the operator. Steerable
robotic catheters with intuitive control may overcome some of the limita-
tions of standard catheter technology, enhance target vessel cannulation,
reduce instrumentation, and improve overall performance scores.Robot-assisted laparoscopic repair of renal artery aneurysms
Pier Cristoforo Giulianotti, Francesco Maria Bianco, Pietro Addeo, Antonella
Lombardi, Andrea Coratti, Fabio Sbrana
Objective: The aim of this article is to report our experience in the repair of
renal artery aneurysms using robot-assisted surgery.
Methods: Between December 2002 and March 2009, five women with a mean
age of 63.8 years (range, 57-78 years) underwent robot-assisted laparoscopic
Abstracts 519repair of renal artery aneurysms by the same surgeon at two different insti-
tutions, the Department of General Surgery, Misericordia Hospital, Grosseto,
Italy (three patients) and the Division of Minimally Invasive and Robotic
Surgery at the University of Illinois, Chicago (two patients). The mean size
of the lesions was 19.4 mm (range, 9-28 mm). Four of the lesions were
complex aneurysms involving the renal artery bifurcation. Two patients
were symptomatic and three had hypertension. In situ repair by aneurys-
mectomy was performed in all cases, followed by revascularization. In
complex aneurysms, an autologous saphenous vein graft was used for the
reconstruction.
Results: The mean operative time was 288 minutes (range, 170-360 min) and
the estimated surgical blood loss was 100 ml (range, 50-300 ml). Warm
ischemia time was 10 minutes in the patient treated by aneurysmectomy,
followed by direct reconstruction. The average warm ischemia time was
38.5 minutes (range, 20-60 min) for patients treated with saphenous vein
graft interposition. The mean time to resume a regular diet was 1.6 days
(range, 1-2 days). The mean postoperative length of hospital stay was 5.6
days (range, 3-7 days). No postoperative morbidity was noted. The mean
follow-up time for the entire series was 28 months (range, 6-48 months).
Color Doppler ultrasonography examination showed patency in all recon-
structed vessels. One patient had stenosis of one of the reconstructed
branches, which was treated with percutaneous angioplasty.
Conclusions: Robot-assisted laparoscopic repair of renal artery aneurysms
is feasible, safe and effective. The technical advantages of the robotic
system allows for microvascular reconstruction to be performed using
a minimally invasive approach, even in complex cases. This approach may
also allow for improved postoperative recovery and reduce the morbidity
correlated with open repair of renal artery aneurysms. Although more expe-
rience and technical refinements are necessary, robot-assisted laparoscopic
repair of renal artery aneurysms represents a valid alternative to open
surgery.A retrospective multicentric study of endovascular treatment of popliteal
artery aneurysms
Dominique Midy, Xavier Berard, Michel Ferdani, Pierre Alric, Vincenzo Brizzi,
Eric Ducasse, Gerard Sassoust
Purpose: To evaluate the feasibility of endovascular exclusion of popliteal
artery aneurysm (PAA) using stent grafts.
Methods: The clinical data of all patients who underwent endovascular
exclusion of PAA at three French vascular departments between December
1999 and December 2007 were retrospectively analyzed. Outcome measures
included graft patency and endoleak. The Kaplan-Meier method was used to
calculate the primary and secondary patency curves.
Results: A total of 57 PAA in 50 patients (48 men; mean age, 72  11 years;
range, 57-96 years) were treated. The type of stent graft used was Hemo-
bahn/Viabahn in 42 (73.7%) cases, Wallgraft in 14 (24.5%) and Passager in
one. The mean duration of hospitalization was 5  1.8 days (range, 3-11
days). No patients were lost from follow up (mean, 36  19.4 months; range,
6-96 months). Nine (16%) occlusions and six (10.5%) endoleaks occurred. The
global limb salvage rate was 96.5% (55 of 57 PAA). Kaplan-Meier estimates for
primary and secondary patency were 85.8% and 87.5% at one year and 82.3%
and 87.5% at three years.
Conclusions: Endovascular treatment of PAA is feasible in selected patients.
The main determinants of success are suitable aneurysm anatomy and dual
antiplatelet postoperative therapy. Further studies are warranted to deter-
mine long-term outcomes of endovascular repair for PAA.A prospective randomized controlled study with intermittent mechanical
compression of the calf in patients with claudication
Joaquin de Haro, Francisco Acin, Aurora Florez, Silvia Bleda, Jose Luis
Fernandez
Objectives: The study tested the feasibility of using a new portable
mechanical compression device for the treatment of claudication. The
device applies intermittent non-pneumatic mechanical compression (IMC)
to the calf. It was hypothesized that it can offer a low-cost convinient
option for patients and achieve good compliance and improved clinical
outcomes.Methods: Thirty patients were enrolled in a randomized controlled single
blind study. Fourteen patients were assigned to active IMC. Sixteen control
patients continued with medical treatment alone. Outcomes were recorded
at baseline, after one month, three months, and six months. The study
examined changes in exercise tolerance using Initial Claudiacation Distance
(ICD) and Absolute Claudiaction Distance (ACD) as well as ankle-brachial
index at rest (ABI-r) and post-exercise (ABI-pe). All patients had stable clau-
dication due to peripheral arterial disease (PAD) and were already under
best medical treatment (BMT). To be eligible for inclusion, patients had to
be between the ages of 50 and 75 years, had to have stable claudication with
an absolute claudication distance >40 meters but <300 meters on a stan-
dardized treadmill stress test (3.8 km/h at a 10% grade), have a resting
ABI in the affected limb <0.8 with a drop of at least 0.15 following exercise,
in whom surgical intervention was not expected for at least three months.
Fourteen patients were assigned to active IMC consisting of compressions
65 mm Hg in amplitude, applied for three 3-second compressions/minute,
two hours/day for three months. Sixteen control patients continued with
BMT alone.
Results: One month after treatment, ICD increased by 66% (P = .001), ACD
increased by 51.75% (P = .005), and ABI-pe increased by 42% (P = .01). Treat-
ment effects were maintained or further improved after three months. ABI-r
did not increase at any time. Compliance exceeded 80%. Three months
following cessation of therapy, claudication distances and ABI-pe did not
decrease significantly.
Conclusions: We concluded that the use of IMC of the calf for three months
increased claudication distances and led to objective improvements in
ABI-pe. Intermittent mechanical compression may be a useful approach to
patients with continued claudication despite standard medical treatment.Variability and short-term determinants of walking capacity in patients
with intermittent claudication
Alexis Le Faucheur, Be´ne´dicte Noury-Desvaux, Guillaume Mahe´, Thomas
Sauvaget, Jean Louis Saumet, Georges Leftheriotis, Pierre Abraham
Objective: Global positioning system (GPS) recordings can provide valid
information on walking capacity in patients with peripheral arterial disease
(PAD) and intermittent claudication (IC) during community-based outdoor
walking. This study used GPS to determine the variability of the free-living
walking distance between two stops (WDBS), induced by lower-limb pain,
which may exist within a single stroll in PAD patients with IC and the poten-
tial associated parameters obtained from GPS analysis.
Methods: This cross-sectional study of 57 PAD patients with IC was con-
ducted in a university hospital. The intervention was 1-hour free-living
walking in a flat public park with GPS recording at 0.5 Hz. GPS-computed
parameters for each patient were WDBS, previous stop duration (PSD),
cumulated time from the beginning of the stroll, and average walking speed
for each walking bout. The coefficient of variation of each parameter was
calculated for patients with WDBS 5 during their stroll. A multivariate anal-
ysis was performed to correlate WDBS with the other parameters.
Results: Mean (SD) maximal individual WDBS was 1905 (1189) vs 550 (621)
meters for patients with WDBS <5 vs WDBS  5, respectively (P < .001). In
the 36 patients with WDBS  5, the coefficient of variation for individual
WDBS was 43%. Only PSD and cumulated time were statistically associated
with WDBS in 16 and 5 patients, respectively.
Conclusions: A wide short-term variability of WDBS exists and likely contrib-
utes to the difficulties experienced by patients with IC to estimate their
maximal walking distance at leisurely pace. Incomplete recovery from
a preceding walk, as estimated through PSD, seems to dominantly account
for the WDBS in patients with IC.Role of three-dimensional computed tomography venography as
a powerful navigator for varicose vein surgery
Seung-Kee Min, Seong-Yup Kim, Yang Jin Park, Whal Lee, In Mok Jung,
Taeseung Lee, Jongwon Ha, Sang Joon Kim
Purpose: Computed tomography venography (CTV) with three-dimensional
reconstruction can provide complementary road maps for varicose vein
(VV) surgery. The purpose of this study is to verify the role of CTV in the
treatment of VV in terms of advantages and complications.
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high ligation, stripping, and varicosectomy by a single vascular surgeon in
2007. All patients were evaluated with duplex ultrasound and CTV. Patients
with renal dysfunction, allergy to radiocontrast, telangiectasia only, or
treated by endovenous laser therapy (EVLT) were excluded from the study.
Computed tomography (CT) examination was performed with a 16-Multide-
tector CT scanner (Siemens) and 3D images were reconstructed by personal
computer-based software (Rapidia, Infinitt, Seoul, Korea). Medical records
and the CT images were reviewed retrospectively.
Results: VV surgeries were done in 127 limbs of 94 patients (both in 33, right
in 29, and left in 32). There were 56 females and 38 males with the mean age
of 57 years (range, 28-79 years). The CEAP classification was C2-3 EpAsPr.
Perforators larger than 1 mm near the varicose veins were detected and
marked on the CT volume-rendering images. The average numbers of perfo-
rators marked by CTV were 12.07  4.27 in each limb. The perforators were
evaluated by duplex for the presence of reflux (0.5 sec). Mean number of
perforators with reflux in each limb was 1.41  1.67, which were ligated
during the surgery. Incidental detections of other disease were done in six
patients, including uterine myomas, an ovarian cyst, a gallstone, a scrotoal
varicocele, and a pes anserine bursitis. Operation was performed with the
CTV images on screen. CTV was helpful in designing the operation in most
patients. Three-D CTV images of saphenopopliteal junction especially
provided thorough understanding of the complex variable anatomy of the
lesion. There were no CT-related complications, such as renal dysfunction
or allergic reaction.
Conclusions: CT venography can provide excellent road map for VV surgery
without significant complications. It cannot replace duplex ultrasound, but
can provide powerful 3D images for designing operation as well as education
and research.Changes in health-related quality of life after ultrasound-guided foam
sclerotherapy for great and small saphenous varicose veins
Katy A.L. Darvall, Rachel C. Sam, Gareth R. Bate, Stanley H. Silverman,
Donald J. Adam, Andrew W. Bradbury
Background: Health-related quality of life (HRQOL) improves after superfi-
cial venous surgery for varicose veins, but the effect of ultrasound-guided
foam sclerotherapy on HRQOL is unknown. The aim of this study was to
determine changes in HRQOL after ultrasound-guided foam sclerotherapy
for varicose veins.
Methods: Consecutive patients undergoing ultrasound-guided foam scler-
otherapy for varicose veins were sent the Short Form 12 (SF-12) question-
naire, a generic measure of HRQOL, and the Aberdeen Varicose Vein
Symptom Score (AVSS) questionnaire, a disease-specific measure of HRQOL,
1 week before treatment and 1, 6, and 12 months after treatment.
Results: The study enrolled 296 patients (34% male; 395 treated legs) with
a median age of 57 years (range, 22-89 years). Of these, 24% had previous
superficial venous surgery, and 66% were CEAP C2-3 (uncomplicated varicose
veins). Questionnaire completion rates were 82%, 73%, and 69% at 1, 6, and
12 months after treatment. The median Physical Component Summary score
of the SF-12 (higher score indicates better HRQOL) improved from 47.6
pretreatment to 49.4 at 1 month (P < .008, Wilcoxon signed rank test), to
51.9 at 6 months (P < .0005), and to 52.9 at 12 months (P < .0005). The
median AVSS (lower score indicates better HRQOL) improved from 19.0
pretreatment to 16.5 at 1 month (P < .0005), to 8.7 at 6 months (P <
.0005), and to 8.6 at 12 months (P < .0005).
Conclusions: Ultrasound-guided foam sclerotherapy for great and small
saphenous varicose veins leads to significant improvements in generic and
disease-specific HRQOL for at least 12 months after treatment.
